Earnings Preview: CVS Health
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts predicting an EPS of $1.83. Historical data shows CVS Health has a mixed track record of beating EPS estimates, with a positive beat last quarter leading to a 1.32% share price increase. Over the past year, CVS shares have declined by 18.28%, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.
February 06, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CVS Health is anticipated to report an EPS of $1.83 for the upcoming quarter. The company's past performance shows a mixed impact on its stock price following earnings announcements, with a recent positive beat. However, the stock has seen an 18.28% decline over the past year, reflecting a bearish sentiment.
The anticipation of CVS Health's earnings report and its EPS of $1.83 sets a neutral expectation due to its mixed historical earnings performance and recent stock decline. The company's ability to beat the EPS estimate and provide positive future guidance could influence its stock price. However, the significant yearly decline indicates a bearish sentiment that might temper any positive short-term impact from the earnings report.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100